SHP2-targeting PROTAC SP4 is a PROTAC which was developed by connecting pomalidomide with SHP099, and has potential as treatment for SHP2-related diseases, such as various types of cancer. SP4 was found to significantly reduce the growth of Hela cells and promote SHP2 degradation and cell apoptosis.
MedKoo Cat#: 130158
Name: SHP2-targeting PROTAC SP4
CAS#: 2624181-69-5
Chemical Formula: C42H51Cl2N11O8
Exact Mass: 907.3299
Molecular Weight: 908.84
Elemental Analysis: C, 55.51; H, 5.66; Cl, 7.80; N, 16.95; O, 14.08
The following data is based on the product molecular weight 908.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |